Federica Bucci Selected Research

namitecan

12/2012	Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
7/2012	The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.
2/2010	Efficacy of ST1968 (namitecan) on a topotecan-resistant squamous cell carcinoma.
6/2008	Intracellular accumulation and DNA damage persistence as determinants of human squamous cell carcinoma hypersensitivity to the novel camptothecin ST1968.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Federica Bucci Research Topics

Disease

7	Neoplasms (Cancer) 07/2012 - 04/2003
3	Carcinoma (Carcinomatosis) 07/2005 - 04/2003
2	COVID-19 01/2024 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2010 - 06/2008
1	Neuroblastoma 12/2012
1	Medulloblastoma 12/2012
1	Weight Loss (Weight Reduction) 12/2012
1	Primitive Neuroectodermal Tumors (PNET) 12/2012
1	Rhabdomyosarcoma 07/2012
1	Sarcoma (Soft Tissue Sarcoma) 07/2012
1	Hypersensitivity (Allergy) 06/2008
1	Lewis Lung Carcinoma 01/2004

Drug/Important Bio-Agent (IBA)

7	CamptothecinIBA 12/2012 - 04/2003
4	namitecanIBA 12/2012 - 06/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2012 - 02/2010
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2012 - 04/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 02/2010 - 04/2003
2	ST 1481 (Gimatecan)IBA 01/2004 - 04/2003
1	Monoclonal AntibodiesIBA 01/2024
1	VaccinesIBA 01/2022
1	ChemokinesIBA 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012
1	adaroteneIBA 04/2012
1	Peptides (Polypeptides)IBA 11/2010
1	IntegrinsIBA 11/2010
1	LigandsIBA 11/2010
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 02/2010
1	Integrin alphaVIBA 01/2010
1	HydrazonesIBA 01/2010
1	Cyclic PeptidesIBA 01/2010
1	arginyl-glycyl-aspartic acidIBA 01/2010
1	AmidesIBA 01/2010
1	3- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA 07/2005
1	RetinoidsIBA 07/2005
1	DNA (Deoxyribonucleic Acid)IBA 07/2005
1	Liposomes (Liposome)IBA 01/2004
1	Hormones (Hormone)IBA 04/2003
1	Cytostatic AgentsIBA 04/2003

Therapy/Procedure

1	Therapeutics 11/2010